Crossmark

Genetically engineered phages for therapeutics: proceed with caution

Crossref DOI link: https://doi.org/10.1038/s41591-019-0506-3

Published Online: 2019-06-24

Published Print: 2019-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nair, Aparna

Khairnar, Krishna
License Information

Text and Data Mining valid from 2019-06-24

Version of Record valid from 2019-06-24
More Information

Article History

First Online: 24 June 2019

Competing interests

: The authors declare no competing interests